1. Home
  2. RNAZ vs FGI Comparison

RNAZ vs FGI Comparison

Compare RNAZ & FGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNAZ
  • FGI
  • Stock Information
  • Founded
  • RNAZ 2016
  • FGI 1987
  • Country
  • RNAZ United States
  • FGI United States
  • Employees
  • RNAZ N/A
  • FGI N/A
  • Industry
  • RNAZ Biotechnology: Pharmaceutical Preparations
  • FGI Industrial Specialties
  • Sector
  • RNAZ Health Care
  • FGI Industrials
  • Exchange
  • RNAZ Nasdaq
  • FGI Nasdaq
  • Market Cap
  • RNAZ 8.3M
  • FGI 9.4M
  • IPO Year
  • RNAZ 2021
  • FGI 2022
  • Fundamental
  • Price
  • RNAZ $0.32
  • FGI $0.83
  • Analyst Decision
  • RNAZ Strong Buy
  • FGI
  • Analyst Count
  • RNAZ 1
  • FGI 0
  • Target Price
  • RNAZ $3.00
  • FGI N/A
  • AVG Volume (30 Days)
  • RNAZ 606.0K
  • FGI 138.3K
  • Earning Date
  • RNAZ 11-26-2024
  • FGI 11-11-2024
  • Dividend Yield
  • RNAZ N/A
  • FGI N/A
  • EPS Growth
  • RNAZ N/A
  • FGI N/A
  • EPS
  • RNAZ N/A
  • FGI N/A
  • Revenue
  • RNAZ N/A
  • FGI $127,180,460.00
  • Revenue This Year
  • RNAZ N/A
  • FGI $5.53
  • Revenue Next Year
  • RNAZ $100.00
  • FGI $5.05
  • P/E Ratio
  • RNAZ N/A
  • FGI N/A
  • Revenue Growth
  • RNAZ N/A
  • FGI 7.71
  • 52 Week Low
  • RNAZ $0.22
  • FGI $0.70
  • 52 Week High
  • RNAZ $18.68
  • FGI $1.85
  • Technical
  • Relative Strength Index (RSI)
  • RNAZ 33.05
  • FGI 46.96
  • Support Level
  • RNAZ $0.31
  • FGI $0.70
  • Resistance Level
  • RNAZ $0.49
  • FGI $0.99
  • Average True Range (ATR)
  • RNAZ 0.05
  • FGI 0.12
  • MACD
  • RNAZ -0.02
  • FGI -0.02
  • Stochastic Oscillator
  • RNAZ 12.67
  • FGI 43.09

About RNAZ TransCode Therapeutics Inc.

TransCode Therapeutics Inc is a clinical-stage oncology company focused on treating metastatic disease. It is committed to defeating cancer through the intelligent design and effective delivery of RNA therapeutics based on its proprietary TTX nanoparticle platform. The company's lead therapeutic candidate, TTX-MC138, is focused on treating metastatic tumors which overexpress microRNA-10b, a unique, well-documented biomarker of metastasis. In addition, TransCode is developing a portfolio of first-in-class RNA therapeutic candidates designed to overcome the challenges of RNA delivery and thus unlock therapeutic access to a variety of novel genetic targets that could be relevant to treating a variety of cancers.

About FGI FGI Industries Ltd.

FGI Industries Ltd is a supplier of kitchen and bath products. It offers sanitaryware, bath furniture, shower systems, customer kitchen cabinetry, and other accessory items. It is business to business supplier of bath and kitchen products to large retail, wholesale, commercial, and specialty channel customers around the globe. its revenue is generated by sanitaryware. Geographically it operates in the United States, Canada, Europe, Rest of the World, and the majority of its revenue comes from the United States.

Share on Social Networks: